NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Clinical Trials
50 trialsNCT06453642 2026-03-30
GPX
Fluidx Medical Technology, Inc.
Phase NA Active not recruiting
NCT07325578 2026-02-12
EPIOS
Quantum Surgical
Phase NA Not yet recruiting
NCT07379008 2026-01-30
Safety and Efficacy of Non-Setting Paste in Bone Defect Reconstruction
Biovico Sp. z o.o.
Phase NA Completed
NCT07197645 2026-01-13
SOLACE
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 1 Recruiting
NCT06376682 2025-09-22
EPIBONE
Quantum Surgical
Phase NA Completed
NCT04974008 2025-01-22
OST-164-01
Emerald Clinical Inc.
Phase 2 Active not recruiting
NCT03709680 2025-01-14
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Pfizer
Phase 2 Active not recruiting
NCT01896505 2024-01-08
A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma
Karyopharm Therapeutics Inc
Phase 1 Completed
NCT06171282 2023-12-14
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Recruiting
NCT03525392 2023-12-12
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Ipsen
Phase 1 Terminated
NCT02736565 2023-11-13
Pbi-shRNAâ„¢ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Gradalis, Inc.
Phase 1 Completed
NCT04788147 2023-10-31
BIOGUIDE-X
RefleXion Medical
Phase NA Completed
NCT06008483 2023-08-23
A Dose Finding Study to Treat Bone Tumor(s)
QSAM Therapeutics, Inc.
Phase 1 Unknown
NCT05851456 2023-05-09
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Recruiting
NCT05732558 2023-03-09
Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
R.A.W. - S.R.L.
Phase NA Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT00095017 2022-02-16
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)
Organon and Co
Phase 2 Withdrawn
NCT01461252 2021-07-16
Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases
Boston Scientific Corporation
Phase 1 Withdrawn
NCT01461265 2021-07-16
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Boston Scientific Corporation
Phase 1 Completed
NCT04798326 2021-03-15
MW032
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1 Completed
NCT00381095 2021-01-20
COPE
Pfizer
Phase 4 Terminated
NCT02223052 2020-05-12
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
Phase 1 Completed
NCT00981578 2020-03-11
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
InSightec
Phase NA Terminated
NCT00656305 2020-02-05
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
InSightec
Phase NA Completed
NCT04178044 2019-11-26
Phase â… Clinical Study Protocol of GB223 Monoclonal Antibody Injection
Genor Biopharma Co., Ltd.
Phase 1 Unknown
NCT02274623 2019-09-27
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
OPKO Health, Inc.
Phase 1 Completed
NCT03527888 2019-05-21
Study of Anlotinib in Patients With Primary Malignant Bone Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown
NCT01091883 2019-03-13
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
InSightec
Phase NA Completed
NCT00960063 2018-08-27
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT03547557 2018-06-06
BM005
InSightec
Phase NA Completed
NCT00211211 2017-12-08
FREE Study - Fracture Reduction Evaluation
Medtronic Spinal and Biologics
Phase 4 Completed
NCT00099177 2017-08-16
A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain
Hoffmann-La Roche
Phase 3 Terminated
NCT00099203 2017-08-16
A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
Hoffmann-La Roche
Phase 3 Terminated
NCT00478270 2017-08-16
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
Hoffmann-La Roche
Phase 2 Withdrawn
NCT02293031 2017-03-07
Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery
NextGen Company Limited
Phase NA Unknown
NCT00434447 2017-02-27
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT01640847 2017-02-07
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases
Imunon
Phase 2 Withdrawn
NCT02561039 2016-11-02
A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease
Hoffmann-La Roche
Phase 3 Completed
NCT02564107 2016-11-02
A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
Hoffmann-La Roche
Phase 4 Completed
NCT02716792 2016-03-23
A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT01085565 2016-03-08
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
InSightec
Phase 2 Completed
NCT02553707 2015-09-17
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00538239 2015-02-13
SUCCEED
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00502736 2014-01-22
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
Hoffmann-La Roche
Phase 2 Completed
NCT01310816 2013-12-05
A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
Infinity Pharmaceuticals, Inc.
Phase 2 Completed
NCT00558272 2013-05-27
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
AstraZeneca
Phase 2 Completed
NCT00350233 2012-09-17
MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors
InSightec
Phase 1 Completed
NCT00423254 2010-08-03
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
Mannkind Corporation
Phase 1 Completed
NCT00035620 2010-02-26
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
Amgen
Phase 2 Completed